[Preterm premature rupture of membranes: CNGOF Guidelines for clinical practice - Short version]

Autor: T, Schmitz, L, Sentilhes, E, Lorthe, D, Gallot, H, Madar, M, Doret-Dion, G, Beucher, C, Charlier, C, Cazanave, P, Delorme, C, Garabedian, É, Azria, V, Tessier, M-V, Senat, G, Kayem
Přispěvatelé: Génétique, Reproduction et Développement (GReD ), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020])-Centre National de la Recherche Scientifique (CNRS)
Jazyk: francouzština
Rok vydání: 2018
Předmět:
Antenatal corticosteroids
Fetal Membranes
Premature Rupture
MESH: Premature Birth
health care facilities
manpower
and services
MEDLINE
education
MESH: Fetal Membranes
Premature Rupture
Pre-viable premature preterm rupture of membranes
Gestational Age
Infections
MESH: Prognosis
[SDV.BDLR.RS]Life Sciences [q-bio]/Reproductive Biology/Sexual reproduction
MESH: Pregnancy
Preterm premature rupture of membranes
MESH: Risk Factors
Pregnancy
Risk Factors
Rupture prématurée des membranes avant viabilité fœtale
MESH: Gestational Age
Antibioprophylaxie
Rupture prématurée des membranes avant terme
Humans
MESH: MEDLINE
Antibiotic prophylaxis
Fetal Death
health care economics and organizations
MESH: Humans
MESH: Infant
Newborn
MESH: Infections
Infant
Newborn
Pregnancy Outcome
Déclenchement du travail
MESH: Pregnancy Outcome
Prognosis
MESH: France
Pregnancy Complications
MESH: Pregnancy Complications
MESH: Fetal Death
Premature Birth
Female
France
Induction of labor
MESH: Female
Corticostéroïdes anténatals
Zdroj: Gynécologie Obstétrique Fertilité & Sénologie
Gynécologie Obstétrique Fertilité & Sénologie, Elsevier, 1970, 46 (12), pp.998-1003. ⟨10.1016/j.gofs.2018.10.016⟩
Gynécologie Obstétrique Fertilité & Sénologie, 1970, 46 (12), pp.998-1003. ⟨10.1016/j.gofs.2018.10.016⟩
ISSN: 2468-7189
2468-7197
Popis: To determine management of women with preterm premature rupture of membranes (PPROM).Bibliographic search from the Medline and Cochrane Library databases and review of international clinical practice guidelines.In France, PPROM rate is 2 to 3% before 37 weeks of gestation (level of evidence [LE] 2) and less than 1% before 34 weeks of gestation (LE2). Prematurity and intra-uterine infection are the two major complications of PPROM (LE2). Compared to other causes of prematurity, PPROM is not associated with an increased risk of neonatal mortality and morbidity, except in case of intra-uterine infection, which is associated with an augmentation of early-onset neonatal sepsis (LE2) and of necrotizing enterocolitis (LE2). PPROM diagnosis is mainly clinical (professional consensus). In doubtful cases, detection of IGFBP-1 or PAMG-1 is recommended (professional consensus). Hospitalization of women with PPROM is recommended (professional consensus). There is no sufficient evidence to recommend or not recommend tocolysis (grade C). If a tocolysis should be prescribed, it should not last more than 48hours (grade C). Antenatal corticosteroids before 34 weeks of gestation (grade A) and magnesium sulfate before 32 weeks of gestation (grade A) are recommended. Antibiotic prophylaxis is recommended (grade A) because it is associated with a reduction of neonatal mortality and morbidity (LE1). Amoxicillin, 3rd generation cephalosporins, and erythromycin in monotherapy or the association erythromycin-amoxicillin can be used (professional consensus), for 7 days (grade C). However, in case of negative vaginal culture, early cessation of antibiotic prophylaxis might be acceptable (professional consensus). Co-amoxiclav, aminosides, glycopetides, first and second generation cephalosporins, clindamycin, and metronidazole are not recommended for antibiotic prophylaxis (professional consensus). Outpatient management of women with clinically stable PPROM after 48hours of hospitalization is a possible (professional consensus). During monitoring, it is recommended to identify the clinical and biological elements suggesting intra-uterine infection (professional consensus). However, it not possible to make recommendation regarding the frequency of this monitoring. In case of isolated elevated C-reactive protein, leukocytosis, or positive vaginal culture in an asymptomatic patient, it is not recommended to systematically prescribe antibiotics (professional consensus). In case of intra-uterine infection, it is recommended to immediately administer an antibiotic therapy associating beta-lactamine and aminoside (grade B), intravenously (grade B), and to deliver the baby (grade A). Cesarean delivery should be performed according to the usual obstetrical indications (professional consensus). Expectative management is recommended before 37 weeks of gestation in case of uncomplicated PPROM (grade A), even in case of positive vaginal culture for B Streptococcus, provided that an antibiotic prophylaxis has been prescribed (professional consensus). Oxytocin and prostaglandins are two possible options to induce labor in case of PPROM (professional consensus).Expectative management is recommended before 37 weeks of gestation in case of uncomplicated PPROM (grade A).
Databáze: OpenAIRE
Externí odkaz: